We found the effects of SM treatment in CCl4-induced liver fibrosis was correlated with the increased hepatic NK activity, which was manifested through the elevated frequency of hepatic NK cells, since NKG2D and NKp46, the activation receptors of NK cells, were apparently up-regulated by SM treatment. The gene discussed is KLRK1; the disease is Hepatic fibrosis.